Stay updated on PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.

Latest updates to the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.4.1 to v3.4.2. This is a minor version update and does not change the study details or user-facing functionality.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.1%

- Check15 days agoChange DetectedAdded a 'Show glossary' option and updated metadata labels to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'; removed the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check30 days agoChange DetectedRevision history updated to reflect addition of v3.3.4 and removal of v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded Locations section including Queensland and South Australia; updated the page revision to v3.3.3.SummaryDifference0.3%

- Check80 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no core study content or details appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.